Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1968 2
1975 1
1978 1
1979 1
1983 1
1989 1
1992 1
1998 3
2003 2
2005 2
2006 1
2007 3
2008 4
2009 6
2010 8
2011 11
2012 3
2013 10
2014 11
2015 6
2016 12
2017 6
2018 10
2019 14
2020 17
2021 26
2022 15
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
[Predictive biomarkers in oncologic uropathology].
Reis H, Szarvas T, Grünwald V. Reis H, et al. Among authors: szarvas t. Pathologe. 2019 May;40(3):264-275. doi: 10.1007/s00292-019-0606-3. Pathologe. 2019. PMID: 31073639 Review. German.
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Széles Á, Fazekas T, Váncsa S, Váradi M, Kovács PT, Krafft U, Grünwald V, Hadaschik B, Csizmarik A, Hegyi P, Váradi A, Nyirády P, Szarvas T. Széles Á, et al. Among authors: szarvas t. Cancer Immunol Immunother. 2023 May;72(5):1061-1073. doi: 10.1007/s00262-022-03328-9. Epub 2022 Nov 16. Cancer Immunol Immunother. 2023. PMID: 36385210 Free PMC article. Review.
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Kói T, Ács N, Hegyi P, Hadaschik B, Nyirády P, Szarvas T. Fazekas T, et al. Among authors: szarvas t. Eur Urol Oncol. 2023 Sep 16:S2588-9311(23)00174-8. doi: 10.1016/j.euo.2023.09.001. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37722977 Free article. Review.
Urachal cancer-current concepts of a rare cancer.
Reis H, Szarvas T. Reis H, et al. Among authors: szarvas t. Pathologe. 2019 Jun;40(Suppl 1):31-39. doi: 10.1007/s00292-018-0516-9. Pathologe. 2019. PMID: 30895340 Review. English.
[Predictive biomarkers in bladder cancer].
Reis H, Szarvas T. Reis H, et al. Among authors: szarvas t. Pathologe. 2019 Dec;40(Suppl 3):331-338. doi: 10.1007/s00292-019-00688-5. Pathologe. 2019. PMID: 31705236 Review. German.
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Váradi A, Kói T, Lang Z, Ács N, Kopa Z, Hegyi P, Hadaschik B, Grünwald V, Nyirády P, Szarvas T. Fazekas T, et al. Among authors: szarvas t. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):665-672. doi: 10.1038/s41391-022-00626-2. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509931 Free PMC article. Review.
[Current diagnostic and treatment strategies for urachal cancer].
Módos O, Váradi M, Dér B, Keszthelyi A, Szűcs M, Reis H, Nyirády P, Szarvas T. Módos O, et al. Among authors: szarvas t. Orv Hetil. 2023 Apr 23;164(16):602-609. doi: 10.1556/650.2023.32754. Print 2023 Apr 23. Orv Hetil. 2023. PMID: 37087728 Review. Hungarian.
175 results